Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Latest News

New Lancet Commission calls for urgent action to tackle Europe’s rising liver disease burden

New Lancet Commission calls for urgent action to tackle Europe’s rising liver disease burden Every day in Europe, nearly 780 people die from cirrhosis or…

MICROB-PREDICT Consensus Survey for Hepatology Experts

We invite you to complete this short Consensus Survey in preparation for the MICROB-PREDICT Consensus Conference on Wednesday, 27 May 2026, during EASL Congress in…

A tribute to Dr Ahmed Elsharkawy

The EASL community is deeply saddened by the loss of Dr Ahmed Elsharkawy, consultant transplant hepatologist, researcher, educator, and valued member of the EASL Governing…

Alcohol abstinence can lead to regression of existing liver-related complications

Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown…

New A-TANGO Score for better patient stratification

We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology….

EASL Urges Support for WHO Resolution – “Steatotic Liver Disease – A Missing Piece in the Global Noncommunicable Disease Response”

Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark…

LIVERAIM Webinar: Early detection of Chronic Liver Disease in primary care, Real-world perspectives

EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must…

Discover the THRIVE and GENIAL activities at EASL Liver Cancer Summit 2026

THRIVE ACTIVITIES AT EASL LIVER CANCER SUMMIT 2026 The overall aim of the THRIVE project is to improve the outcome of both paediatric and adult…

Become part of the next generation of EASL’s leadership in 2026!

Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following position:…

On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling.

PRESS RELEASE 3 December 2025 On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL)…
Scroll to Top

Search EASL